导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -27.36% | 1038/1050 |
| 近一周 | -2.17% | 741/1104 |
| 近一月 | -2.31% | 408/1103 |
| 近一季 | -9.87% | 697/1092 |
| 近半年 | -27.11% | 1051/1070 |
| 近一年 | -18.86% | 885/1018 |
| 近两年 | 38.20% | 608/926 |
| 近三年 | 19.87% | 502/834 |
| 成立以来 | 274.72% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.02% 971/1070 |
-17.68% 1054/1101 |
- - |
- - |
| 2025 | 55.79% 144/1065 |
12.27% 94/1014 |
8.36% 149/1038 |
16.99% 694/1050 |
9.46% 55/1065 |
| 2024 | 15.58% 157/1011 |
10.86% 23/960 |
-3.25% 527/983 |
11.86% 463/991 |
-3.67% 584/1011 |
| 2023 | 14.88% 11/952 |
20.43% 28/880 |
-0.75% 227/895 |
3.70% 11/915 |
-7.31% 708/952 |
| 2022 | -18.09% 259/867 |
-14.97% 261/773 |
8.41% 334/806 |
-7.54% 122/845 |
-3.91% 601/867 |
| 2021 | -4.18% 406/740 |
-4.55% 323/580 |
4.86% 470/659 |
-8.16% 453/704 |
4.24% 253/740 |
| 2020 | 64.37% 169/554 |
3.30% 91/419 |
28.73% 144/466 |
4.46% 370/517 |
18.32% 146/554 |
| 2019 | 52.48% 133/410 |
32.91% 225/1149 |
-6.34% 802/1231 |
9.37% 121/390 |
11.99% 109/410 |
| 2018 | -25.83% 160/349 |
- - |
- - |
- - |
-7.19% 113/1080 |
| 2017 | 9.04% 139/285 |
- - |
- - |
- - |
- - |
| 2016 | -11.06% 69/205 |
- - |
- - |
- - |
- - |
| 2015 | 8.04% 59/151 |
- - |
- - |
- - |
- - |
| 2014 | 38.09% 4/24 |
- - |
- - |
- - |
- - |
| 2013 | 15.58% 10/21 |
- - |
- - |
- - |
- - |
| 2012 | 1.44% 116/157 |
- - |
- - |
- - |
- - |
| 2011 | -33.56% 100/102 |
- - |
- - |
- - |
- - |
| 2010 | 8.61% 4/58 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 汇丰晋信中小盘股票 VS. 东吴新产业精选股票A(580008) |